GSK’s Promacta Effective In Raising Platelet Count In HCV-Associated Thrombocytopenia, Phase II Data Show

Results published in the New England Journal of Medicine demonstrate 95 percent of hepatitis C patients with thrombocytopenia taking 75 mg dose of eltrombopag once daily had elevated platelet counts.